Navigation Links
Apricoxib Prolongs Time-to-Progression and Overall Survival in Biomarker-Selected NSCLC Patients
Date:6/6/2011

CHICAGO and SAN DIEGO, June 6, 2011 /PRNewswire/ -- Tragara Pharmaceuticals, Inc. announced today that apricoxib (Capoxigem®, TG01) in combination with erlotinib demonstrated significant and consistent clinical benefit over erlotinib alone in a clinically relevant subset of biomarker-selected patients with non-small cell lung cancer (NSCLC) who had previously failed a platinum-containing regimen for advanced disease. Complete data from the study, APRiCOT-L, were presented during the annual meeting of the American Society for Clinical Oncology (ASCO) in Chicago. Apricoxib is Tragara's novel, oral, once-daily COX-2 inhibitor in development for the treatment of a variety of cancers.

In the trial "APRiCOT-L: A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination with Erlotinib in Non-Small Cell Lung Cancer Patients" (Abstract #7528, Poster #17), combination therapy with apricoxib and erlotinib demonstrated significant benefits over erlotinib and placebo in the subset of patients < 65 years-of-age including:

  • 71% improvement in disease control rate;
  • 93% improvement in median progression-free survival; and
  • 205% improvement in median overall survival.

"APRiCOT-L results demonstrating clinical benefit are the first reported for a study that employed modulation of a functional biomarker to prospectively select patients for treatment with a COX-2 inhibitor," stated Barbara Gitlitz, MD, Associate Professor of Clinical Medicine, USC/Norris Comprehensive Cancer Center Keck School of Medicine. "The benefits seen in TTP and OS are impressive and apricoxib is a promising new agent advancing into Phase III development."

The study, a Phase II randomized, double-blind, multi-center, placebo-controlled trial, evaluated time-to-progression as the primary endpoint in 120 patients at oncology centers in th
'/>"/>

SOURCE Tragara Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Tragara Pharmaceuticals Apricoxib Reverses EMT, a Key Process for Cancer Progression and Metastasis
2. Prostate Cancer Immunotherapy Significantly Prolongs Survival in Men With Advanced Prostate Cancer
3. Data Presented at AUA Demonstrate PROVENGE Significantly Prolongs Survival for Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
4. Treating Depression Prolongs Life for Older People with Diabetes
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Bayers Investigational Compound Radium-223 Chloride Met its Primary Endpoint of Significantly Improving Overall Survival in a Phase III Trial in Patients with Castration-Resistant Prostate Cancer That Has Spread to the Bone
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
9. Dendreon Announces Exercise and Closing of Overallotment Option
10. Pharmasset Announces Exercise of Underwriters Overallotment Option
11. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LYNBROOK, N.Y. , Sept. 19, 2014  BioSpecifics Technologies ... first in class collagenase-based products marketed as XIAFLEX ® ... announced today that BioSpecifics, President, Tom Wegman , will ... BioCentury NewsMakers in the Biotech Industry Conference. ... at 3:00 p.m. EDT at the Millennium Broadway Hotel in ...
(Date:9/19/2014)... , Sept. 19, 2014 Intarcia ... interim clinical data for its lead candidate ITCA 650 ... patients with high baseline HbA1c levels at the 50 ... the Study of Diabetes (EASD). Data from the open-label, ... levels of blood sugar in patients with poorly controlled ...
(Date:9/19/2014)... -- PCI is pleased to announce it has acquired ... provider of Clinical Trial Services and Temperature Controlled ... in the United Kingdom ... in the UK/EU to support global investigational studies ... distribution capacity, as well as consultative services for ...
Breaking Medicine Technology:BioSpecifics Technologies Corp. to Present at the 21st Annual BioCentury NewsMakers in the Biotech Industry Conference 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
... MedCath Corporation,(Nasdaq: MDTH ) announced today that ... which MedCath owns an interest, has entered into ... (the DOJ) and the United,States Attorneys, Office in ... The settlement concerns Medicare claims submitted between June ...
... from the,CORONA study presented today at the American ... statin to optimized heart failure,treatment did not significantly ... because it could not reverse or prevent the,deterioration ... CRESTOR(R) (rosuvastatin calcium) 10 mg,experienced an 8 percent ...
Cached Medicine Technology:Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter 2New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 2New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 3New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 4New Data Examines the Effect of Adding a Statin to Optimized Treatment for Patients with Advanced Heart Failure 5
(Date:9/19/2014)... 2014 (HealthDay News) -- When it comes to firearm ... United States, while the District of Columbia has the ... decade, deaths from gun-related violence -- including murders, suicides ... States, the study revealed. Hawaii,s rate was roughly three ... spectrum, the District of Columbia had the highest rate ...
(Date:9/19/2014)... WASHINGTON (Sept. 19, 2014) Shahram Majidi, M.D., ... at the George Washington University School of Medicine ... the American Heart Association to study the presence ... with intracerebral hemorrhage (ICH). , "According to epidemiological ... percent of all strokes, but is the least ...
(Date:9/19/2014)... Top 10 Best SEO Hosting, a leading review ... Bluehost are among the best web hosting suppliers ... suppliers for webmasters from the USA, UK, Canada, ... hosting (including VPS and cloud hosting). , HostGator.com ... hosting companies that started thinking Green. The company ...
(Date:9/19/2014)... 19, 2014 Capital Region Periodontics ... is excited to announce the latest addition to ... gingivitis and those needing dental implants. Often referred ... treatment removes the fear factor normally associated with ... discomfort and bleeding make, this procedure a very ...
(Date:9/19/2014)... with advanced, incurable cancer do not receive any palliative ... month at the ESMO 2014 Congress in Madrid, Spain, ... at the same time as 15 new oncology centres ... awarded the prestigious title of ,ESMO Designated Centre of ... Alexandru Grigorescu, medical oncology consultant at the Institute of ...
Breaking Medicine News(10 mins):Health News:U.S. Gun Deaths Lowest in Hawaii, Highest in D.C. 2Health News:GW researcher receives grant to study brain swelling following bleeding in the brain 2Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 2Health News:Albany, NY Periodontist Reed Ference, DMD, Calms Fears of Patients with Gum Disease by Offering LANAP®, An Advanced, Less Invasive Treatment Solution 3Health News:Patients with advanced, incurable cancer denied palliative care 2Health News:Patients with advanced, incurable cancer denied palliative care 3Health News:Patients with advanced, incurable cancer denied palliative care 4
... The Marxist Communist Party (CPI-M) leader, Brinda Karat has ... allegation that medicines produced at Ramdev's pharmacy were contaminated ... ,The notice issued on behalf of B.D. ... alleged that Karat's 'mischievous act was supposed to cause ...
... patients in the local paper Edith Paulus, 59 years old called ... Nesdoly, GP, would not take patients older than 45. She was ... to be accepted by a doctor. ,After a two-year ... due to age discrimination. In response to this Nesdoly, who has ...
... researchers at University of Texas have developed artificial, super-strength muscles ... ,As it appears in Science, these artificial muscles are 100 ... ,Two types of muscle are being investigated by US researchers ... Dallas, working with colleagues from South Korea. ,Both release the ...
... A new study in the March 17 issue of the ... used to treat Alzheimer’s disease is also useful in improving ... patients after they undergo radiation therapy.// ,Researchers at ... tumor patients who were treated for six months with donepezil ...
... quitting the NHS on April 1. Dentists in England and ... by April 1st. Several Cumbrian practices have // already opted ... notice when leaving the NHS. ,But now due ... few days notice. The North Cumbria Primary Care Trusts (PCTs) ...
... boy battling life with life support should be kept alive, ... High Court. // This is a landmark judgement, especially, since ... support, to allow him to die, rather than prolong a ... ,The Judge’s ruling disallowed the NHS trust to sweep aside ...
Cached Medicine News:Health News:Physicians Get To Choose Their Patients 2Health News:Alzheimer’s Disease Drug Could Improve Quality Of Life After Radiatio 2
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
... has been selling replacement bulbs ... and we are extremely proud ... Check out our catalog of ... discount light bulbs specials. ...
... been selling replacement bulbs on ... we are extremely proud of ... out our catalog of replacement ... light bulbs specials. ,Check ...
Medicine Products: